Damora Therapeutics, Inc.
USD24.52
+0.30 (+1.26%)
CEO
Jennifer A. Jarrett
IPO Date
2026-03-10
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$24.46
Prev. Close
$24.21
Day Low
$24.46
Day High
$24.52
52W Low
$2.45
52W High
$38.33
Market Cap
$1.51B
Volume
0.01M
| 500,000 |
| $0.00 |
| 1 Apr 2026 | Jarrett Jennifer | director, officer: See Remarks | A-Award | Acquired | 1,500,000 | $25.50 |
| 1 Apr 2026 | Jarrett Jennifer | — | Disposed | 0 | $0.00 |
| 25 Mar 2026 | Winslow Garrett | General Counsel | A-Award | Acquired | 250,000 | $23.05 |
| 25 Mar 2026 | Turtle Cameron | director | A-Award | Acquired | 37,313 | $23.05 |
| 25 Mar 2026 | Landsittel Michael | director | A-Award | Acquired | 37,313 | $23.05 |
| 25 Mar 2026 | Fairmount Funds Management LLC | director, 10 percent owner: | A-Award | Acquired | 37,313 | $23.05 |
| 25 Mar 2026 | CAIN CHRISTOPHER W. | director | A-Award | Acquired | 37,313 | $23.05 |
| 25 Mar 2026 | Bruno Julianne | director | A-Award | Acquired | 37,313 | $23.05 |